Table 1.
Characteristics | Control (n = 8) | aTAA (n = 10) | aTAD (n = 10) |
---|---|---|---|
Age (y) | 63.9 ± 8.4 | 66.5 ± 8.9 | 62.9 ± 9.0 |
Male | 4 (50%) | 5 (50%) | 6 (60%) |
Hypertension | 6 (75%) | 10 (100%) | 10 (100%) |
COPD | 1 (13%) | 1 (10%) | 1 (10%) |
Diabetes mellitus | 2 (25%) | 2 (20%) | 2 (20%) |
History of smoking | 3 (38%) | 4 (40%) | 6 (60%) |
Use of anti-lipid medication | 2 (25%) | 2 (20%) | 1 (10%) |
Use of COX inhibitor | 3 (38%) | 6 (60%) | 5 (50%) |
Aortic diameter (cm) | NA | 6.0 ± 0.9 | 5.4 ± 0.8 |
Data are expressed as a number (percent) or as the mean ± standard deviation. aTAA, ascending thoracic aortic tissue from patients with ascending thoracic aortic aneurysm; aTAD, ascending thoracic aortic tissue from patients with acute ascending thoracic aortic dissection; COPD, chronic obstructive pulmonary disease; COX, cyclooxygenase; NA, not available.